Leaflet: information for the user
Inovelon100mgfilm-coated tablets
Inovelon200mgfilm-coated tablets
Inovelon400mgfilm-coated tablets
Rufinamide
Read this leaflet carefully before you start taking the medicine, because it contains important information for you.
1.What is Inovelon and what it is used for
2.What you need to know before starting to take Inovelon
3.How to use Inovelon
4.Possible side effects
5.Storage of Inovelon
6.Contents of the pack and additional information
Inovelon contains a medicine called rufinamide. It belongs to a group of medicines called antiepileptics, which are used to treat epilepsy (a disease that causes seizure crises or epileptic attacks).
Inovelon is used with other medicines to treat seizure crises associated with Lennox-Gastaut syndrome in adults, adolescents, and children over 1 year of age. Lennox-Gastaut syndrome is the name given to a group of severe epilepsies in which repeated crises of various types may occur.
Your doctor has prescribed Inovelon to reduce the number of crises or attacks.
Do not take Inovelon:
-if you are allergic to rufinamide, triazolides, or any of the other components of Inovelon (listed in section 6).
Warnings and precautions
Consult your doctor or pharmacist:
Please consult your doctor, even if you experienced these effects at some point in the past.
Children
Inovelon should not be used in children under 1 year of age because there is not enough information on its use in this age group.
Use of Inovelon with other medications
Inform your doctor or pharmacist if you are using or have recently used other medications, including those purchased without a prescription. If you are using the following medications: phenobarbital, fosphenytoin, phenytoin, or primidone,you may need to be closely monitored for two weeks at the beginning or end of treatment with rufinamide, or after any significant changes in dose. You may need to adjust the dose of the other medications as they may be less effective when taken with rufinamide.
Antiepileptics and Inovelon
If your doctor prescribes or recommends additional treatment for epilepsy (e.g., valproate), inform them that you are taking Inovelon, as you may need to adjust your dose.
Taking valproate at the same time as rufinamide in children and adults will result in high levels of rufinamide in the blood. Inform your doctor if you are taking valproate, as your doctor may need to adjust your dose of Inovelon.
Inform your doctor if you use oral contraceptives/hormonal contraceptives, such as "the pill." Inovelon may make the pill ineffective in preventing pregnancy. Therefore, it is recommended that you use an additional safe and effective contraceptive method (such as a barrier method, e.g., condoms) while using Inovelon.
Inform your doctorif you use blood thinners, such as warfarin. Your doctor may need to adjust your dose.
Inform your doctorif you use digoxin (a medication used to treat heart conditions).Your doctor may need to adjust your dose.
Taking Inovelon with food and drinks
See section 3 "How to use Inovelon" for recommendations on taking Inovelon with food and drinks.
Pregnancy, breastfeeding, and fertility
If you are pregnant or think you may be pregnant, or if you plan to become pregnant, consult your doctor or pharmacist before using this medication. You should only take Inovelon during pregnancy if your doctor advises it.
It is recommended that you do not breastfeed while taking Inovelon, as it is unknown whether rufinamide passes into breast milk.
If you are a woman of childbearing age, you should use contraceptive methods while taking Inovelon.
Consult your doctor or pharmacist before using any medication at the same time as Inovelon.
Driving and operating machinery
Inovelon may cause dizziness, drowsiness, and affect your vision, especially at the beginning of treatment or after a dose increase. If this happens, do not drive or operate machinery.
Inovelon contains lactose
If your doctor has told you that you have intolerance to some sugars, contact your doctor before taking this medication.
Inovelon contains sodium
This medication contains less than 1 mmol of sodium (23 mg) per daily dose; it is essentially "sodium-free."
Follow exactly the administration instructions of this medication as indicated by your doctor. In case of doubt, consult your doctor or pharmacist again.
Children between one and four years of age
The recommended starting dose is 10 mg per kilogram of body weight per day. Two equal doses are taken, half in the morning and the other half at night. Your doctor will calculate your dose and may increase it by 10 mg per kilogram of body weight every three days.
The maximum daily dose will depend on whether you are or are not taking valproate. The maximum daily dose without valproate is 45 mg per kilogram of body weight per day. The maximum daily dose with valproate is 30 mg per kilogram of body weight per day.
Children 4 years of age or older who weigh less than 30 kg
The recommended starting dose is 200 mg per day. Two equal doses are taken, half in the morning and the other half at night. Your doctor will calculate your dose and may increase it by 200 mg (5 ml) every three days.
The maximum daily dose will depend on whether you are or are not taking valproate. The maximum daily dose without valproate is 1,000 mg per day. The maximum daily dose with valproate is 600 mg per day.
Adults, adolescents, and children who weigh 30 kg or more
The recommended starting dose is 400 mg per day. Two equal doses are taken, half in the morning and the other half at night. Your doctor will calculate your dose and may increase it by 400 mg every other day.
The maximum daily dose will depend on whether you are or are not taking valproate. The maximum daily dose without valproate cannot exceed 3,200 mg, depending on your body weight. The maximum daily dose with valproate cannot exceed 2,200 mg, depending on your body weight.
Some patients may respond to lower doses, and your doctor may adjust your dose based on your response to treatment.
If you experience any adverse effects, your doctor may increase your dose more slowly.
Inovelon tablets should be taken twice a day with water, in the morning and at night. Inovelon should be taken with food. If you have difficulty swallowing, you can crush the tablet, then mix the powder in approximately half a glass of water (100 ml) and drink it immediately. You can also divide the tablets into two equal halves and swallow them with water.
Do not reduce the dose or stop taking this medication unless your doctor tells you to.
If you take more Inovelon than you should
If you think you have taken more Inovelon than you should, inform your doctor or pharmacist immediately, or contact the nearest hospital emergency department, bringing the medication with you.
If you forget to take Inovelon
If you forget to take a dose, continue taking the medication as usual. Do not take a double dose to make up for the missed dose. If you forget to take more than one dose, consult your doctor.
If you interrupt treatment with Inovelon
If your doctor tells you to stop treatment, follow their instructions regarding the gradual reduction of Inovelon to reduce the risk of increased seizures.
If you have any other questions about the use of this medication, ask your doctor or pharmacist.
Like all medicines, Inovelon can cause side effects, although not everyone will experience them.
The following side effects can be very serious:
Skin rash and/or fever. They may be signs of an allergic reaction. If this happens, inform your doctor or go to the hospital immediately.
Change in the types of seizures you experience/longer-lasting seizures (called status epilepticus). Inform your doctor immediately.
A small number of people taking antiepileptic medicines like Inovelon have had suicidal thoughts or behaviors. If you ever have these thoughts, contact your doctor immediately (see section2).
You may experience the following side effects with this medicine. Inform your doctor if you experience any of the following side effects:
The very common side effects (affecting more than 1 in 10 patients) of Inovelon are:
Dizziness, headache, nausea, vomiting, drowsiness, fatigue.
The common side effects (affecting more than 1 in 100 patients) of Inovelon are:
Neurological problems that include: difficulty walking, abnormal movements, seizures/convulsions, unusual eye movements, blurred vision, tremors.
Gastrointestinal problems that include: stomach pain, constipation, indigestion, soft stools (diarrhea), loss or change in appetite, weight loss.
Infections: ear infection, flu, nasal congestion, lung infection
Additionally, patients have experienced: anxiety, insomnia, nosebleeds, acne, skin rash, back pain, infrequent menstruation, bruises, head and brain injuries (as a result of an accidental injury during a seizure).
The uncommon side effects (affecting between 1 in 100 and 1 in 1,000 patients) of Inovelon are:
Allergic reactions and an increase in liver function markers (elevated liver enzymes).
Reporting side effects
If you experience any type of side effect, consult your doctor, even if it is a possible side effect not listed in this leaflet.You should also report them directly through the Spanish System for Pharmacovigilance of Medicines for Human Usewww.notificaRAM.es. By reporting side effects, you can contribute to providing more information about the safety of this medicine.
Keep this medication out of the sight and reach of children.
Do not use this medication after the expiration date that appears on the blister pack and on the box. The expiration dateis the last day of the month indicated.
Do not store at a temperature above30°C.
Do not use this medication if you observe that it has changed in appearance.
Medicines should not be disposed of through drains or in the trash. Ask your pharmacist how to dispose of the packaging and of the medication that you no longer need. In this way, you will help to protect the environment.
Composition of Inovelon
Each film-coated tablet of100mg contains100mg of rufinamide.
Each film-coated tablet of200mg contains200mg of rufinamide.
Each film-coated tablet of400mg contains400mg of rufinamide.
Appearance of Inovelon and contents of the package
It is available inpacks of 10, 30, 50, 60, and 100 film-coated tablets.
It is available inpacks of 10, 30, 50, 60, and 100 film-coated tablets.
It is available inpacks of 10, 30, 50, 60,100, and 200 film-coated tablets.
Holder of the marketing authorization and responsible for manufacturing
Holder of the marketing authorization:
Eisai GmbH
Edmund-Rumpler-Straße 3
60549 Frankfurt am Main
Germany
e-mail: [email protected]
Responsible for manufacturing:
.
Eisai GmbH
Edmund-Rumpler-Straße 3
60549 Frankfurt am Main
Germany
You can request more information about this medicine by contacting the local representative of the holder of the marketing authorization:
Eisai SA/NV Tél/Tel: +32 (0)800 158 58 | Lietuva Eisai GmbH Tel: + 49 (0) 69 66 58 50 |
???????? Eisai GmbH Te?.: + 49 (0) 69 66 58 50 | Luxembourg/Luxemburg Eisai SA/NV Tél/Tel: +32 (0)800 158 58 (Belgique/Belgien) |
Ceská republika Eisai GesmbH organizacni složka Tel: + 420 242 485 839 | Magyarország Eisai GmbH Tel.: + 49 (0) 69 66 58 50 |
Danmark Eisai AB Tlf: + 46 (0) 8 501 01 600 (Sverige) | Malta Associated Drug Co. Ltd Tel: + 356 2277 8000 |
Deutschland Eisa GmbH Tel: + 49 (0)69 66 58 50 | Nederland Eisai B.V. Tél/Tel: + 31 (0) 900 575 3340 |
Eesti Eisai GmbH Tel: + 49 (0) 69 66 58 50 (Saksamaa) | Norge Eisai AB Tlf: + 46 (0) 8 501 01 600 (Sverige) |
Ελλ?δα Arriani Pharmaceutical S.A. Τηλ: + 30 210 668 3000 | Österreich Eisai GesmbH Tel: + 43 (0) 1 535 1980-0 |
España Eisai Farmacéutica, S.A. Tel: + (34) 91 455 94 55 | Polska Eisai GmbH Tel: + 49 (0) 69 66 58 50 (Niemcy) |
France Eisai SAS Tél: + (33) 1 47 67 00 05 | Portugal Eisai Farmacêtica, Unipessoal Lda Tel: + 351 214 875 540 |
Hrvatska Eisai GmbH Tel: + 49 (0) 69 66 58 50 | România Eisai GmbH Tel: + 49 (0) 69 66 58 50 (Germania) |
Ireland Eisai GmbH Tel: + 49 (0) 69 66 58 50 | Slovenija Eisai GmbH Tel: + 49 (0) 69 66 58 50 (Nemcija) |
Ísland Eisai AB Sími: + 46 (0)8 501 01 600 (Svíþjóð) | Slovenská republika Eisai GesmbH organizacni složka Tel.: + 420 242 485 839 (Ceská republika) |
Italia Eisai S.r.l. Tel: + 39 02 5181401 | Suomi/Finland Eisai AB Puh/Tel: + 46 (0) 8 501 01 600 (Ruotsi) |
Κ?προς Arriani Pharmaceuticals S.A. Τηλ: + 30 210 668 3000 (Ελλ?δα) | Sverige Eisai AB Tel: + 46 (0) 8 501 01 600 |
Latvija Eisai GmbH Tel: + 49 (0) 69 66 58 50 (Vacija) | United Kingdom (Northern Ireland) Eisai GmbH Tel: + 49 (0) 69 66 58 50 (Germany) |
Last review date of this leaflet:
The detailed information about this medicine is available on the website of the European Medicines Agency: http://www.ema.europa.eu
Есть вопросы по этому лекарству или вашим симптомам? Свяжитесь с лицензированным врачом для получения помощи и персонализированного ухода.